The American Benefits Council (ABC) issued a release outlining what payers should expect legislatively post-election including COVID-19 relief and stimulus legislation, Affordable Care Act expansion, and other efforts to ensure Americans have access to the coverage they need. “Without the support of a fully Democratic Congress, President-elect Biden’s broad health plan will be largely stalled,” the release ...
As available ICU beds remain at critically low levels, Gov. Gavin Newsom on Monday warned that the state’s regional stay-at-home order would be extended in certain parts of the state as early as Tuesday, the latest sign that California’s battle against COVID-19 wages on.
As COVID-19 cases surge, Covered California is urging uninsured residents to sign up for coverage by this Wednesday’s deadline.
Telemetry nurses in California normally take care of four patients at once. But after the state relaxed California’s unique nurse-to-patient ratios in mid-December, Nerissa Black has to keep track of six.
2020 was a year dominated by the fallout from a generational global pandemic. So perhaps it's no surprise that COVID-19 headlines also governed much of our coverage over the course of this year, as we shared the latest on how the coronavirus pandemic was impacting you.
In the recent "IDC FutureScape: Worldwide Health Industry 2021 Predictions" report, experts at IDC Health Insights offer their thoughts about the issues healthcare and life science organizations will contend with over the next year and beyond.
Under the proposed rule, providers would be able to disclose patient data if they believe it's in the patient's best interest.
Increases in spending on hospital care, physician services and prescription drugs squeezed U.S. commercial health insurers in 2019, according to new federal government health spending data.
Fed-up Californians have been trading their cramped, pricey apartments for affordable living in cheaper states for decades. Now, California’s businesses are making similar calculations after a months long remote work experiment triggered by the pandemic.
Pfizer said Wednesday it will supply the U.S. government with an additional 100 million doses of its COVID-19 vaccine under a new agreement between the pharmaceutical giant and the Trump administration. Pfizer and its German partner BioNTech said that will bring their total current commitment to 200 million doses for the U.S. That should be ...